Showing results (231-240 of 318) with videos related to

Sort By:
Pageof 32
Pediatric Nephrology (Berlin, Germany)|July 19, 2014
Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in childrenZhaoyang Peng, Jianhua Mao, Xuejun Chen, et al.
Plant Diversity|January 13, 2022
Genome-wide identification and expression analysis of NtbHLH gene family in tobacco (<i>Nicotiana tabacum</i>) and the role of NtbHLH86 in drought adaptationGe Bai, Da-Hai Yang, Peijian Chao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 5, 2025
Sono-Controllable Janus Hydrogel Platform for Sequential Tumor Eradication and Bone Regeneration in Metastatic Breast CancerYitong Li, Yunyun Liu, Chuyun Lou, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in renal and hepatic impairment patientsXuejun Chen, Jack G Shi, Thomas Emm, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 9, 2022
Genomic Scar Score: A robust model predicting homologous recombination deficiency based on genomic instabilityWuzhou Yuan, Jing Ni, Hao Wen, et al.
Blood|April 27, 2018
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphomaTycel J Phillips, Andres Forero-Torres, Taimur Sher, et al.
Pediatric Blood & Cancer|May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
BMC Medical Imaging|April 7, 2026
Multimodal radiomics for early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer: integration of amide proton transfer weighted imaging in radiomicsMingzhe Xu, Ailing Wang, Dongqiu Shan, et al.
European Journal of Radiology|October 1, 2025
Longitudinal changes in tumor morphology and body composition following neoadjuvant chemotherapy predict progression-free survival in adenocarcinoma of the esophagogastric junction: A multi-center studyChenglong Luo, Wanling Mu, Haojie Zhang, et al.
European Journal of Pharmacology|June 21, 2021
Editing flagellin derivatives for exploration of potent radioprotective agentsTong Shi, Jun Jiang, Meng Gao, et al.
Pageof 32